Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors
Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors
Recruiting · NCT07259889 · Registry updated 2025-12-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors | Advanced Solid Tumors (Phase 1) | Recruiting | Phase 1 | 2025-12-02 | NCT07259889 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Xiling Biotechnology Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 17 |